-
1 month ago | 
statnews.com | Anil Oza |Katherine MacPhail
As Francis Collins, longtime director of the National Institutes of Health, took to the steps below the Lincoln Memorial on Friday for a sound check before speaking at the Stand Up for Science rally, he was confronted by an agitated protester who warned, “You’re going to prison.” The incident was witnessed by a reporter from STAT, and the man afterward identified himself only as “Jeff” and said he was there to protest Collins’ oversight of NIH, and specifically the agency’s funding of...
-
1 month ago | 
statnews.com | Anil Oza |Katherine MacPhail
WASHINGTON, D.C. — Days after retiring from the National Institutes of Health, the agency’s former director warned that two signature programs — an initiative to decipher how the brain works, and another to build a massive and diverse genomics database — are threatened by Trump administration actions.
-
1 month ago | 
statnews.com | Katherine MacPhail
Last month, researchers in South Africa were preparing to administer two experimental HIV vaccines in a Phase 1 clinical trial. The staff was trained, immunizations were ready, and participant screening had begun. Then, they received a stop-work order: The $45 million in funding from USAID to support the project was frozen under a 90-day review — and could be withdrawn completely.
-
Oct 18, 2024 | 
statnews.com | Katherine MacPhail
Former Trump White House official Joe Grogan at the STAT Summit.Screen Capture via STAT BOSTON — There are huge stakes for health care in the upcoming U.S. election — and leaders from across the political spectrum weighed in on policy priorities for the next U.S. president at STAT’s flagship Summit.
-
May 16, 2024 | 
statnews.com | Katherine MacPhail |Mario Aguilar
SAN FRANCISCO — In the world of drug discovery, AI progress is often measured by a single-mile marker: When will we get an AI-designed drug? The answer remains, ambiguously, “the future,” but at STAT’s Breakthrough Summit leaders from NVIDIA and Google insisted that the impact of AI is visible today.
-
Apr 29, 2024 | 
statnews.com | Katherine MacPhail
WASHINGTON — Nicholas Voyles, executive director of the Indiana Recovery Alliance, ended up missing his daily dose of methadone on Monday. He’d requested “guest dosing” before traveling to Washington, but discovered that day that the paperwork hadn’t been processed yet. Although he has requested guest doses in clinics across America, Voyles told an audience at the STAT policy in health care meeting, the process has only worked a single time.
-
Mar 15, 2024 | 
statnews.com | Katherine MacPhail
WASHINGTON — John Green, the popular novelist and YouTube star, gave the health care world a taste of his clout last year when he and his “Nerdfighter” fan base pressured corporations to cut prices for tuberculosis treatment. This week, he announced a more collaborative strategy for fighting tuberculosis — a public-private funding partnership with USAID and the Philippines.
-
Nov 8, 2023 | 
statnews.com | Katherine MacPhail
WASHINGTON – With the prevalence of some chronic diseases trending up, the U.S. needs to revamp its approaches to preventative care and disease management, experts said at the Milken Health Summit on Tuesday. Already, six in 10 Americans live with a chronic condition, and four in 10 live with at least two.
-
Sep 11, 2023 | 
statnews.com | Katherine MacPhail |Mario Aguilar |Matthew Herper |Angus Chen |Adam Feuerstein
STAT Team / Katherine MacPhail Katherine MacPhail Programmer, Editorial Events Katherine MacPhail is an editorial events programmer at STAT. Before joining STAT, Katherine covered federal health IT and climate resilience for GovCIO Media & Research. Katherine graduated from Oberlin College, where she served as editor-in-chief of The Oberlin Review. Based out of Washington, D.C., she loves live music, rock climbing, and books. Politics Katherine MacPhail STAT Plus: Expanded methadone access:...
-
Jun 6, 2023 | 
scribd.com | Matthew Herper |Angus Chen |Adam Feuerstein |Katherine MacPhail
STAT+: ASCO showcased the payoff for new cancer medicines: longer lives As new cancer drugs arrive, regulators and doctors still struggle with when to use drugs based on earlier data and when to wait for survival data. #ASCO23 by Matthew Herper and Angus Chen and Adam Feuerstein and Katherine MacPhailChicago was big and beautiful enough to hold thousands of visitors for the ASCO meeting — and Taylor Swift's tour. CHICAGO — Well, that’s a wrap.
